Algés, Oeiras Mon to Sat · 09:00 to 13:00 and 14:00 to 19:00
WhatsApp Book a consultation
  1. Home
  2. Aesthetic gynaecology
  3. Vaginal atrophy
  4. Genitourinary syndrome of menopause

Genitourinary syndrome of menopause: what it is and why it replaced "atrophy"

The new name for vaginal atrophy brings together genital, sexual and urinary symptoms with the same cause. See what it includes, why it changed and what that means for you.

Rúben BritoAuthor
Dr Michelle CampagnoliClinical review · OM no. 69467
7 min read
Foto de capa · a do cartão do blog1200 × 800 px (3:2)
Quando existir, entra aqui e também no cartão da página do blog.
In this article
  1. In short
  2. What genitourinary syndrome of menopause is
  3. Why we stopped saying "atrophy"
  4. What changes for you
  5. How it is diagnosed
  6. How it is treated
  7. When to see a doctor
  8. At Luxmed Clinic
  9. Frequently asked questions

If you have heard your doctor talk about "genitourinary syndrome of menopause", you are hearing the current name for what for decades was called vaginal atrophy or vulvovaginal atrophy. The change was proposed in 2014 by two international scientific societies and is not merely a matter of words (Portman and Gass, 2014).

The new name recognises that a lack of oestrogen affects not only the vagina, but also the vulva, the urethra and the bladder, and that sexual and urinary symptoms are part of the same picture.

In 30 seconds

Three ideas to remember.

1The current name for vaginal atrophyIt includes genital, sexual and urinary symptoms caused by the fall in oestrogen. "Atrophy" was dropped because it was incomplete and had a negative connotation.
2Chronic and progressiveIt does not usually ease with time, but it has effective treatment.
3Talking is the first stepMany women do not talk to their doctor about these symptoms, and so go without treatment.
Imagem opcional · abertura1200 × 800 px
Fica por baixo do resumo, se existir uma segunda foto.

What genitourinary syndrome of menopause is

GSM is defined as a set of symptoms and signs associated with the fall in oestrogen and other sex hormones, involving changes in the labia majora and minora, the clitoris, the vaginal entrance, the vagina, the urethra and the bladder (Portman and Gass, 2014).

To speak of GSM, the symptoms must be bothersome and must not be better explained by another condition, such as an infection or a skin condition of the vulva (Portman and Gass, 2014, NAMS, 2020).

The three groups of symptoms

GroupSymptoms
Genitaldryness, burning, itching, irritation
Sexuallack of lubrication, discomfort or pain during intercourse, poorer sexual function
Urinaryurgency to pass urine, burning when passing urine, recurrent urinary infections

A woman may have symptoms from just one group or from several. Many do not link frequent trips to the toilet or repeated cystitis to the menopause, and treat them as separate problems.

How many women it affects

Studies estimate that about half of postmenopausal women have GSM symptoms, although the figures vary a great deal depending on how they are measured (NAMS, 2020). Unlike hot flushes, GSM does not usually ease with time.

Why we stopped saying "atrophy"

In 2014, the International Society for the Study of Women's Sexual Health and the North American Menopause Society convened a panel of experts to review the terminology. The reasons for the change were (Portman and Gass, 2014):

  • The term was incomplete. "Vulvovaginal atrophy" described only the appearance of the genital tissues and left out the urinary symptoms, which have the same origin.
  • The word "atrophy" had a negative connotation. It suggests wasting away and ageing, and many women did not identify with it.
  • It was not an easy term to use. The experts considered that a more neutral name would make conversation between women and doctors, and public discussion of the subject, easier.
  • It described signs, not symptoms. Atrophy is seen on examination; GSM is defined by what the woman feels and by what the doctor observes.
BeforeNow
Vaginal atrophy, vulvovaginal atrophy, atrophic vaginitisGenitourinary syndrome of menopause
Focus on the vaginaVulva, vagina, urethra and bladder
Focus on the appearance of the tissuesFocus on symptoms and the impact on the woman's life

Criticisms of the new name

The term also has limitations. The one most often pointed out is that it includes the word "menopause", although the same changes can arise before it: during breastfeeding, with breast cancer treatments or with medicines that suppress the ovaries. That is why, in practice, both terms are still used, and "vaginal atrophy" still appears in many studies and leaflets.

What changes for you

The name matters because it changes how symptoms are looked for and treated:

  • Urinary symptoms enter the conversation. Repeated cystitis or urgency to pass urine after the menopause may have the same cause as vaginal dryness, and local treatment can help with both (NAMS, 2020, Perrotta et al., 2008).
  • Pain during intercourse is taken seriously. It is not "normal for your age" or something to put up with.
  • It is a chronic condition. It needs a long-term plan, and symptoms tend to come back if treatment stops (NAMS, 2020).

There is also a problem still to be solved: in international surveys, many women with these symptoms never mentioned them to their doctor, out of embarrassment, because they thought they were inevitable or because they did not know there was treatment (Nappi and Kokot-Kierepa, 2012, Kingsberg et al., 2013). Talking about it is the first step.

How it is diagnosed

There is no specific test for GSM. The diagnosis is made at the consultation, based on symptoms and examination (NAMS, 2020). The doctor looks for signs such as a thin, pale lining, loss of the vaginal folds, small areas of bleeding or narrowing of the vaginal entrance. They may measure the vaginal pH, which tends to be above 5.

The consultation also serves to rule out other causes with similar symptoms, such as infections, skin conditions of the vulva or contact allergies. If there are urinary symptoms, a urine test may be requested.

How it is treated

The treatment is the same as that used for vaginal atrophy and depends on the severity of the symptoms and on your health history (NAMS, 2020):

  • vaginal lubricants and moisturisers, for mild symptoms;
  • low-dose vaginal oestrogen, the treatment with the most evidence, which improves genital symptoms and reduces recurrent urinary infections (Perrotta et al., 2008, Lethaby et al., 2016);
  • vaginal prasterone or oral ospemifene, as alternatives in selected cases;
  • pelvic floor physiotherapy, when there is associated pain or muscle tension.

Laser or radiofrequency treatments do not yet have enough evidence to be recommended as a first option (NAMS, 2020).

In women with a history of breast cancer, the treatment should be decided together with the oncology team.

When to see a doctor

Book a consultation if, after the menopause or during a period of low oestrogen

Tick what applies to you.

Any vaginal bleeding after the menopause should be assessed by a doctor, even if it is slight.

If you have any doubts about the symptoms, call SNS 24 (808 24 24 24). In case of heavy bleeding, severe pain or a high fever with lower back pain, call 112.

At Luxmed Clinic

At the gynaecological aesthetics consultation, we assess the genital, sexual and urinary symptoms together, examine the vulva and the vagina and rule out other causes before proposing a plan.

The plan is tailored to you and your health history, based on what the scientific evidence supports. When necessary, we work together with your own doctor, urologist or oncologist.

Talk to us

The assessment is a conversation, with no obligation. Tell us what concerns you and our team will reply.

info@luxmed.pt

This article is for information only and does not replace a medical assessment. Results vary from person to person.

Frequently asked questions

Are genitourinary syndrome of menopause and vaginal atrophy the same thing?

In essence, yes. GSM is the current and broader name, which also includes symptoms of the vulva and the urinary tract.

Why is it called a "syndrome"?

Because it brings together several symptoms and signs with the same cause, the fall in oestrogen, in different organs.

Can I have GSM before the menopause?

The same changes can arise when oestrogen is low for other reasons, such as breastfeeding, breast cancer treatments or removal of the ovaries.

Can repeated urinary infections be GSM?

They can be related. After the menopause, the protective vaginal flora decreases, which makes infections easier. Vaginal oestrogen reduces this risk.

Can GSM be cured?

It does not go away by itself, because the cause persists. But the symptoms can be well controlled with continued treatment.

Which doctor treats GSM?

Your GP or gynaecologist can make the diagnosis and start treatment. For persistent urinary symptoms, assessment by urology can be useful.

Scientific references 6
  1. Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Menopause. 2014;21(10):1063-8. Artigo
  2. The North American Menopause Society. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976-92. Guideline
  3. Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA): results from an international survey. Climacteric. 2012;15(1):36-44. Artigo
  4. Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med. 2013;10(7):1790-9. Artigo
  5. Perrotta C, Aznar M, Mejia R, Albert A, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008;(2):CD005131. Revisão Cochrane
  6. Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;(8):CD001500. Revisão Cochrane
Written byRúben BritoOperial Development
Clinical reviewDr Michelle CampagnoliOM no. 69467 · Doctor with Competence in Aesthetic Medicine.View profile →

Book a consultation

Book your consultation

Choose how you prefer to get in touch. We will arrange the assessment consultation with Dr Michelle Campagnoli.

Booking through the websiteAssessment consultationTalk to our assistant on WhatsApp and ask for the current price of the assessment.

New Life Miraflores, Algés · Office Center, R. Santa Teresa do Menino Jesus n.º 6, 9.º C, 1495-048

Your details are used only for this contact. Any treatment depends on a prior medical assessment.

Request an appointmentIt takes less than a minute.
Speciality
You do not need to go into detail. The doctor will talk to you during the consultation.
Request received. Our team will contact you as soon as possible.
CallAssistantAvailableBook